We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
Alpha Dhabi has also reinforced its balance sheet with total assets standing at AED 177.5 billion, a 26% increase YoY, while ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The government says it is "playing our part to unshackle the energy sector, and now the sector must deliver. Otherwise, further action will be inevitable." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback